These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38917723)

  • 1. Update on the assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form-2 (ATHF-SF2).
    Sackeim HA; Aaronson ST; Bunker MT; Conway CR; George MS; McAlister-Williams RH; Prudic J; Thase ME; Young AH; Rush AJ
    J Psychiatr Res; 2024 Aug; 176():325-337. PubMed ID: 38917723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF).
    Sackeim HA; Aaronson ST; Bunker MT; Conway CR; Demitrack MA; George MS; Prudic J; Thase ME; Rush AJ
    J Psychiatr Res; 2019 Jun; 113():125-136. PubMed ID: 30974339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?
    Dodd S; Bauer M; Carvalho AF; Eyre H; Fava M; Kasper S; Kennedy SH; Khoo JP; Lopez Jaramillo C; Malhi GS; McIntyre RS; Mitchell PB; Castro AMP; Ratheesh A; Severus E; Suppes T; Trivedi MH; Thase ME; Yatham LN; Young AH; Berk M
    World J Biol Psychiatry; 2021 Sep; 22(7):483-494. PubMed ID: 33289425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Vagus Nerve Stimulation Significantly Improves Quality of Life in Treatment-Resistant Major Depression.
    Conway CR; Kumar A; Xiong W; Bunker M; Aaronson ST; Rush AJ
    J Clin Psychiatry; 2018 Aug; 79(5):. PubMed ID: 30152645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A computer algorithm for calculating the adequacy of antidepressant treatment in unipolar and bipolar depression.
    Oquendo MA; Baca-Garcia E; Kartachov A; Khait V; Campbell CE; Richards M; Sackeim HA; Prudic J; Mann JJ
    J Clin Psychiatry; 2003 Jul; 64(7):825-33. PubMed ID: 12934985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide Study.
    Lundberg J; Cars T; Lööv SÅ; Söderling J; Sundström J; Tiihonen J; Leval A; Gannedahl A; Björkholm C; Själin M; Hellner C
    JAMA Psychiatry; 2023 Feb; 80(2):167-175. PubMed ID: 36515938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of antidepressant treatment of psychiatric patients with depressive disorders: treatment adequacy and outcomes.
    von Knorring J; Baryshnikov I; Jylhä P; Talaslahti T; Heikkinen M; Isometsä E
    BMC Psychiatry; 2023 Nov; 23(1):888. PubMed ID: 38017416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adequacy of antidepressant treatment by psychiatric residents: the antidepressant treatment history form as a possible assessment tool.
    Dew RE; Kramer SI; McCall WV
    Acad Psychiatry; 2005; 29(3):283-8. PubMed ID: 16141125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persisting low use of antipsychotics in the treatment of major depressive disorder with psychotic features.
    Andreescu C; Mulsant BH; Peasley-Miklus C; Rothschild AJ; Flint AJ; Heo M; Caswell M; Whyte EM; Meyers BS;
    J Clin Psychiatry; 2007 Feb; 68(2):194-200. PubMed ID: 17335316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An episode level evaluation of the treatment journey of patients with major depressive disorder and treatment-resistant depression.
    Wu B; Cai Q; Sheehan JJ; Benson C; Connolly N; Alphs L
    PLoS One; 2019; 14(8):e0220763. PubMed ID: 31393922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adults.
    Machmutow K; Meister R; Jansen A; Kriston L; Watzke B; Härter MC; Liebherz S
    Cochrane Database Syst Rev; 2019 May; 5(5):CD012855. PubMed ID: 31106850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant-resistant depression is characterized by reduced short- and long-interval cortical inhibition.
    Jeng JS; Li CT; Lin HC; Tsai SJ; Bai YM; Su TP; Chang YW; Cheng CM
    Psychol Med; 2020 Jun; 50(8):1285-1291. PubMed ID: 31155020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining treatment-resistant depression.
    Gaynes BN; Lux L; Gartlehner G; Asher G; Forman-Hoffman V; Green J; Boland E; Weber RP; Randolph C; Bann C; Coker-Schwimmer E; Viswanathan M; Lohr KN
    Depress Anxiety; 2020 Feb; 37(2):134-145. PubMed ID: 31638723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
    Daly EJ; Trivedi MH; Janik A; Li H; Zhang Y; Li X; Lane R; Lim P; Duca AR; Hough D; Thase ME; Zajecka J; Winokur A; Divacka I; Fagiolini A; Cubala WJ; Bitter I; Blier P; Shelton RC; Molero P; Manji H; Drevets WC; Singh JB
    JAMA Psychiatry; 2019 Sep; 76(9):893-903. PubMed ID: 31166571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression.
    Nguyen KH; Gordon LG
    Value Health; 2015 Jul; 18(5):597-604. PubMed ID: 26297087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological therapies for treatment-resistant depression in adults.
    Ijaz S; Davies P; Williams CJ; Kessler D; Lewis G; Wiles N
    Cochrane Database Syst Rev; 2018 May; 5(5):CD010558. PubMed ID: 29761488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility to Treatment-Resistant Depression Within Families.
    Cheng CM; Chen MH; Tsai SJ; Chang WH; Tsai CF; Lin WC; Bai YM; Su TP; Chen TJ; Li CT
    JAMA Psychiatry; 2024 Jul; 81(7):663-672. PubMed ID: 38568605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial report.
    Conway CR; Aaronson ST; Sackeim HA; Duffy W; Stedman M; Quevedo J; Allen RM; Riva-Posse P; Berger MA; Alva G; Malik MA; Dunner DL; Cichowicz I; Luing H; Zajecka J; Nahas Z; Mickey BJ; Kablinger AS; Kriedt CL; Bunker MT; Lee YL; Shy O; Majewski S; Olin B; Tran Q; Rush AJ
    Brain Stimul; 2024; 17(2):448-459. PubMed ID: 38574853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of treatment resistant depression episodes in a cohort of patients from a US commercial claims database.
    Kubitz N; Mehra M; Potluri RC; Garg N; Cossrow N
    PLoS One; 2013; 8(10):e76882. PubMed ID: 24204694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression: Managing Resistance and Partial Response to Treatment.
    Gaddey HL; Mason B; Naik A
    Am Fam Physician; 2024 May; 109(5):410-416. PubMed ID: 38804755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.